Flu vaccine strain selection
Executive Summary
Influenza virus strains to be included in the vaccine for the 2005-2006 season will be reviewed by FDA's Vaccines & Related Biological Products Advisory Committee Feb. 16. Committee will hear updates on FDA's Critical Path Initiative and CBER research programs on Feb. 17. The meeting will be held at the Bethesda, Md. Holiday Inn at 8:30 a.m. on both days. [Editor's Note: To 1watch a webcastor order a video/DVD of this meeting, visit FDAAdvisoryCommittee.com.]...